What GLP-1 Does Aetna Cover in 2026?
The plain-English coverage map — by plan, by drug, and by diagnosis — so you don’t ask your doctor for the wrong medication or waste a prior authorization.
Published: · Last reviewed:
How we built this: we read Aetna’s public 2026 drug guides and clinical policy bulletins, Aetna’s Medicare coverage pages, CVS Caremark’s 2026 formulary announcements, the CMS page for the Medicare GLP-1 Bridge, and the FDA approval records for these drugs. This is general information, not medical advice. Your exact coverage is plan-specific.
Disclosure: The RX Index may earn a commission if you start care through a partner link. It never changes what we report. The only ones who decide your coverage are Aetna, your plan documents, and your prescriber.
Published by The RX Index, the independent GLP-1 decision resource. Evaluated with our RX Index Score methodology.
If you searched “what GLP-1 does Aetna cover,” here’s the straight answer: Aetna covers GLP-1 medications — but which one it covers for you comes down to three things: your specific plan, your diagnosis, and whether your employer paid to include weight-loss drugs. For type 2 diabetes, Aetna’s drug lists commonly include Ozempic, Mounjaro, and Rybelsus (usually with prior approval). For weight loss, Wegovy is the one Aetna most consistently covers, and Zepbound is being added back as co-preferred on October 1, 2026.
That third factor — your employer — is the one nobody warns you about. It’s the reason two people who both “have Aetna” get opposite answers at the pharmacy counter. We’ll show you exactly how to find out which group you’re in.
(Quick definition: a GLP-1 is a class of medication — like semaglutide or tirzepatide — that lowers blood sugar and appetite. Brand names include Ozempic, Wegovy, Mounjaro, and Zepbound.)
Find your situation in 10 seconds
| Your situation | What Aetna most likely covers | The first thing to check |
|---|---|---|
| You have type 2 diabetes | Ozempic, Mounjaro, Rybelsus, or Trulicity (often with prior approval) | Does your plan need prior approval and proof of diagnosis? |
| You want it for weight loss | Wegovy most often; Zepbound depends on the plan | Did your employer include weight-loss drug coverage? |
| You have sleep apnea + obesity | Zepbound may have a covered path | Is the request submitted for sleep apnea, not just weight loss? |
| You have heart disease + obesity | Wegovy may have a covered path | Is it submitted for heart-risk reduction? |
| You’re on Aetna Medicare | GLP-1s for diabetes, heart risk, or sleep apnea — not weight loss | Check your Part D drug list; the separate $50 Bridge may help for weight loss |
| You’re on Aetna Better Health (Medicaid) | It’s state-specific | Check your state’s Medicaid drug list |
| Your plan excludes weight-loss drugs | Likely nothing for weight loss — prior approval won’t fix it | Ask HR if the benefit is excluded |
Not sure which row is you? That’s the most common place people get stuck.
Get your 60-second Aetna GLP-1 path →Free · personalized checklist · no account needed
What GLP-1 does Aetna cover in 2026? The full list
Aetna covers GLP-1 medications in two buckets: diabetes drugs (Ozempic, Mounjaro, Rybelsus, Trulicity) covered for type 2 diabetes, and weight-loss drugs (Wegovy, sometimes Zepbound, with newer oral options emerging) covered only if your plan includes anti-obesity coverage. Most weight-loss GLP-1s need prior authorization, and Aetna runs its prescription benefits through CVS Caremark. Whether your plan covers a specific drug depends on your plan’s drug list and your diagnosis.
| GLP-1 (active ingredient) | Approved for | Typical Aetna coverage | Need-to-know |
|---|---|---|---|
| Ozempic (semaglutide) | Type 2 diabetes | Covered for diabetes (often with prior approval). Not for weight loss alone. | A weight-loss prescription with no diabetes diagnosis is the wrong lane and gets denied. |
| Mounjaro (tirzepatide) | Type 2 diabetes | Covered for diabetes (often with prior approval). Not for weight loss. | For weight loss, the matching drug is Zepbound — don’t mix them up. |
| Rybelsus (oral semaglutide) | Type 2 diabetes | Covered for diabetes (often with prior approval). | A diabetes pill — a different coverage lane than the Wegovy weight-loss pill. |
| Trulicity (dulaglutide) | Type 2 diabetes | Covered for diabetes. | Older diabetes GLP-1; common on Aetna diabetes drug lists. |
| Wegovy (semaglutide 2.4 mg) | Weight management; heart-risk reduction; MASH | Most consistently covered weight-loss GLP-1 — with prior approval, if your plan includes weight-loss coverage. | Aetna’s preferred weight-loss GLP-1 since mid-2025. Comes as a pen and a pill. |
| Zepbound (tirzepatide) | Weight management; obstructive sleep apnea | Depends on your plan. Covered on some, excluded on others. | The most plan-dependent drug here. CVS Caremark adds it back as co-preferred Oct 1, 2026. |
| Foundayo (orforglipron) | Weight management (oral) | Emerging — newly coverable on plans that opt in. | FDA-approved April 1, 2026; the first GLP-1 weight-loss pill you can take any time of day. |
| Saxenda (liraglutide) | Weight management | Sometimes listed, usually as a non-preferred option. | Older daily injection; often kept as a lower-cost alternative. |
Sources: Aetna public 2026 plan drug guides and Clinical Policy Bulletins; CVS Health’s May 28, 2026 formulary announcement; FDA approval records. “Depends on your plan” items must be checked against your own drug list.
A pattern worth knowing. The consistent picture from several public 2026 Aetna plan drug guides: diabetes GLP-1s show up across plans (sometimes with prior authorization, sometimes listed as preferred without one), Wegovy appears in the weight-management section, and Zepbound’s status genuinely changes from plan to plan — covered on some, excluded on others. That’s not a glitch. It’s why you’ll find conflicting answers online.
One honest limit of any table like this: a drug showing up on a public Aetna list does not guarantee your plan covers it. Aetna says your specific plan design may exclude medications, change your cost, or alter coverage based on the condition being treated — and that you need your member login to see your real benefits.
The one thing nobody tells you (read this before you call your doctor)
The single biggest factor in whether Aetna covers a GLP-1 for weight loss isn’t the drug, your weight, or your doctor. It’s whether your employer paid to include weight-loss drugs in your plan at all.
Many employers leave that coverage out to control costs. Aetna confirms it directly: plan sponsors choose whether to include or exclude GLP-1 coverage for weight management. This isn’t theoretical. In late 2025, one Aetna-administered benefit fund told its members that effective January 1, 2026, it would no longer cover GLP-1 medications prescribed for weight loss — citing the rising cost of the drugs. When a plan has that exclusion (called a “carve-out”), prior authorization won’t save you. You can meet every clinical criterion perfectly and still be denied, because the benefit simply isn’t in your plan.
We’re telling you this first because it changes your entire game plan. If your plan carves it out, the worst thing you can do is spend three weeks fighting a prior authorization you can’t win.
But here’s the hopeful part — and it’s bigger than most people realize. If your plan does include weight-loss coverage, in Ro’s 2025 Coverage Checker Report, 43% of users had coverage for a GLP-1 for weight loss, and half of covered patients paid $50 a month or less. And even if your plan excludes plain weight-loss use, two other doors often open: a different covered diagnosis (diabetes, heart disease, sleep apnea, MASH), or a competitive FDA-approved cash-pay route.
So the real first question isn’t “does Aetna cover Wegovy?” It’s “is weight-loss coverage even turned on in my plan?” Five minutes with HR or the number on your card answers it.
Find out if your plan includes weight-loss coverage — and your best next move →Why two people with “the same Aetna” get different answers
Aetna coverage feels random because the same drug can fall into completely different insurance “lanes” — and each lane has its own rules. A GLP-1 can be covered as a diabetes drug, a weight-loss drug, a heart-risk drug, a sleep-apnea drug, or a liver-disease drug, and your employer’s plan design sits on top of all of it. Knowing your lane tells you which door to knock on.
1. The diabetes lane
Ozempic, Mounjaro, Rybelsus, and Trulicity live here. If you have type 2 diabetes, these are usually the cleanest path to coverage (sometimes with prior approval). If you don’t have diabetes and you ask for one of these to lose weight, expect a denial — that’s not bad luck, it’s the rule.
2. The weight-loss lane
Wegovy, Zepbound, Foundayo, and Saxenda live here. This lane has the most coverage and the most exclusions, because this is the benefit employers turn on or off.
3. The medical-indication lane
This is the door people forget. Wegovy is FDA-approved to reduce heart attack and stroke risk in adults with heart disease and excess weight (approved March 2024), and Aetna’s policy also includes a path for Wegovy injection for noncirrhotic MASH. Zepbound is FDA-approved for moderate-to-severe obstructive sleep apnea — when breathing repeatedly stops during sleep — in adults with obesity. These paths can unlock coverage even when the plain weight-loss benefit is excluded.
4. The employer-plan lane (this one overrides the others)
A drug can sit right there on a public Aetna drug list and still be denied because your employer’s version of the plan excluded that benefit.
Does Aetna cover Wegovy?
Aetna usually covers Wegovy for weight loss — with prior authorization, and only if your plan includes weight-loss drug coverage. Wegovy has been Aetna’s preferred weight-loss GLP-1 since mid-2025, so on most plans that cover any weight-loss drug, Wegovy is the most reliable bet.
Wegovy (semaglutide) is the higher-dose version of semaglutide built specifically for weight management. A few things to know:
Wegovy for weight loss
This is the main path. You’ll need prior authorization and you’ll need to meet Aetna’s criteria — BMI, a documented weight-management effort, and so on. Full criteria are in the section below.
Wegovy for heart-risk reduction
If you have established cardiovascular disease and excess weight, Aetna’s policy includes a separate path. Patients with a BMI of 27 or higher and documented heart disease may qualify, and on most plans the 6-month lifestyle-program requirement is waived for this path.
Wegovy for MASH (liver)
Aetna’s current policy includes a path for Wegovy injection for noncirrhotic MASH with moderate-to-advanced scarring — a separate, specialized route your specialist would document.
Wegovy pen vs. Wegovy pill
They aren’t the same for cost or pharmacy logistics. Wegovy now comes as both. Check both on your plan rather than assuming they’re interchangeable.
The bottom line: if your plan covers weight-loss drugs at all, Wegovy is usually the smoothest yes.
Check whether your plan covers Wegovy before your doctor submits the paperwork → (sponsored affiliate link, opens in a new tab)Does Aetna cover Zepbound?
Zepbound coverage under Aetna is genuinely plan-dependent — it’s covered on some Aetna plans and listed as excluded on others, which is why you’ll find conflicting answers online. Aetna’s prescription benefits run through CVS Caremark, which dropped Zepbound from its standard formulary in mid-2025 and is adding it back as a preferred option on October 1, 2026. Whether that affects you depends on whether your employer uses CVS Caremark’s standard list or a customized one.
The CVS Caremark timeline (this is the source of the chaos)
CVS Caremark is the “PBM,” or pharmacy benefit manager — the company that decides which drugs are on the list and negotiates their prices for Aetna and other plans. Three dates matter:
CVS Caremark dropped Zepbound from its standard formulary and made Wegovy the preferred weight-loss GLP-1. This sent a lot of patients scrambling.
CVS Caremark removed the “new-to-market” block on Foundayo (the new oral pill), making it coverable on plans that opt in.
CVS Caremark will add Zepbound back as an additional preferred option, so Wegovy and Zepbound become co-preferred — for plan sponsors who choose to cover it.
What this means for you in mid-2026: On a standard Aetna/CVS Caremark plan today, Wegovy is your covered weight-loss GLP-1 and Zepbound may not be yet. That improves for many plans on October 1. But “co-preferred” does not automatically mean your plan covers it — your employer can still opt out.
Zepbound for sleep apnea
If you have moderate-to-severe obstructive sleep apnea, this is a real path. Aetna’s policy includes a sleep-apnea route that generally requires a sleep study showing an AHI (apnea-hypopnea index) of 15 or higher plus a BMI of 30 or higher. Submitted this way, Zepbound is being requested as a sleep-apnea treatment, not just weight loss — a different and often stronger position.
Important: Wegovy and Zepbound are not interchangeable
They work differently (Zepbound acts on two gut hormones; Wegovy acts on one), and for some people one works far better than the other. If you were forced off Zepbound onto Wegovy, that’s a legitimate reason to ask for an exception — not just a preference.
Already been denied, or told to “try Wegovy first”? That’s a step-therapy issue, and the fix is different from a normal application. → Read our guide to requesting an Aetna formulary exception or beating a “try Wegovy first” denial
Check whether Zepbound is covered, excluded, or needs an exception on your specific plan → (sponsored affiliate link, opens in a new tab)Does Aetna cover Ozempic or Mounjaro for weight loss?
Usually not. Ozempic and Mounjaro are diabetes drugs, and Aetna covers them for type 2 diabetes — not for weight loss on their own. If you ask for Ozempic or Mounjaro to lose weight and you don’t have a diabetes diagnosis, you should expect a denial.
You’ll see Ozempic and Mounjaro sitting right there on your Aetna drug list and think, “Great, I’m covered.” Then your prior authorization gets denied. Why? Because being on the list (the formulary) and being covered for your reason are two different things. These drugs are on the list for diabetes. A claim with a weight-loss diagnosis code instead of a diabetes one gets rejected.
If you have type 2 diabetes
Ozempic and Mounjaro are usually well-covered with prior approval.
If you want to lose weight without diabetes
Ask about Wegovy (semaglutide for weight loss) or Zepbound (tirzepatide for weight loss). Don’t mix them up with their diabetes counterparts.
Does Aetna cover the Wegovy pill or Foundayo?
Oral GLP-1 coverage under Aetna is real but still settling. Some Aetna 2026 materials list Wegovy’s oral tablet in their weight-management sections, and Foundayo — the new orforglipron pill approved by the FDA on April 1, 2026 — became coverable on plans that opt in after CVS Caremark removed its new-to-market block on June 1, 2026. Coverage of these pills is plan-by-plan and changing month to month.
Wegovy oral tablet
Wegovy now comes as a pill, not just a pen, and it appears in Aetna’s weight-management drug sections on some plans (often on a preferred tier, with prior approval). Confirm it specifically — some plans list the pen but not the pill, or vice versa.
Foundayo (orforglipron)
The newest option: the first GLP-1 weight-loss pill you can take any time of day without food or water restrictions. FDA-approved April 1, 2026. CVS Caremark cleared the way for coverage on June 1, 2026, but “cleared the way” isn’t the same as “your plan covers it.” Some Aetna plans had not added it as of mid-2026. Check your own list.
A compliance note: oral compounded semaglutide or tirzepatide sold by some cash-pay websites is not the same as the FDA-approved Wegovy pill or Foundayo. Compounded drugs are not FDA-approved finished products. If your plan covers an FDA-approved oral GLP-1, that’s the cleaner path.
What does Aetna require before it covers a weight-loss GLP-1?
For weight-loss GLP-1s, Aetna’s prior authorization generally requires: age 18+, a BMI of 30 or higher (or 27 or higher with a weight-related condition), and documentation of at least 6 months in a weight-management program. To keep coverage going, you usually need to show at least 5% weight loss after reaching a stable dose. If your plan excludes weight-loss drugs, none of these criteria matter — the exclusion wins.
About that BMI number. Aetna’s policy document carries a “BMI 35” label, which throws people off. But the published criteria for these GLP-1s use the standard thresholds — a BMI of 30 or higher, or 27 or higher with a weight-related condition. Bottom line: if your BMI is in the low 30s, you likely meet the standard criteria — but confirm the exact number on your own plan’s drug policy before you count on it.
What you need for initial approval
| Requirement | Detail |
|---|---|
| Age | 18 or older |
| BMI | 30 or higher, or 27 or higher with at least one weight-related condition (hypertension, high cholesterol, sleep apnea, type 2 diabetes) |
| Weight-management program | Documentation of at least 6 months in a comprehensive program (diet, activity, behavior changes) — waived for heart-disease and sleep-apnea paths |
| Prescriber documentation | Attestation and supporting clinical records |
| Diagnosis match | The right drug for the right FDA-approved use |
What you need to keep it (continuation)
- A stable maintenance dose for a set period (often around 3 months)
- Proof of at least 5% weight loss from your starting weight — or proof you’ve maintained that loss
Step therapy (the “try this first” rule)
Some Aetna plans require you to try a cheaper option first — phentermine, Contrave, or Wegovy — before approving Zepbound. This is called step therapy. It can usually be waived if you document that you already tried it and it failed, or you can’t take it for a medical reason.
The shortcut: let someone handle the paperwork
Prior authorization is the single most frustrating part of getting a GLP-1. The forms, the back-and-forth, the denials — it’s a part-time job. This is where a telehealth provider with a dedicated insurance team earns its keep.
Ro — our pick for Aetna prior authorization
Per Ro’s own pages, Ro checks your insurance for free and sends you a personalized coverage report. If you then join Ro and you’re approved for treatment, Ro’s insurance concierge gets the coverage process started, handles the paperwork, and fights for coverage — for FDA-approved Wegovy pen, Zepbound pen, and Ozempic. If you’re covered, the prescription goes to your pharmacy. If you’re not, your provider can suggest an FDA-approved cash-pay option instead.
Pricing, straight up: get started for $39, then as low as $74/month with the annual plan paid upfront (otherwise $149/month). The membership fee is separate from the cost of the medication.
Honest catch: Ro isn’t free, and the membership fee sits on top of your medication cost. If your only goal is the rock-bottom cash price with zero membership, Ro isn’t built for that. But if your block is insurance — the prior auth, the denials, the runaround — that concierge is doing the exact work you’d otherwise do alone. Ro’s insurance help is for commercial plans only. If you’re on Aetna Medicare or Medicaid, skip this and read the Medicare section.
Medication safety: GLP-1 medications carry serious warnings and possible side effects. Review the FDA Medication Guide for the specific drug and talk with a licensed clinician about whether it’s right for you.
See if you qualify and let Ro start the Aetna coverage process → (sponsored affiliate link, opens in a new tab)Prefer to pick your own provider, or want Costco-member pricing on branded GLP-1s? Sesame Care (sponsored affiliate link, opens in a new tab) is the other route worth a look for branded cash-pay.
Does Aetna Medicare cover GLP-1 drugs?
Aetna Medicare plans do not cover GLP-1 medications for weight loss — federal law bars Medicare Part D from covering drugs used for weight loss. But Aetna Medicare can cover GLP-1s for type 2 diabetes (Ozempic, Mounjaro), for heart-risk reduction (Wegovy), and for obstructive sleep apnea (Zepbound), all with prior approval. Separately, the Medicare GLP-1 Bridge gives eligible Part D beneficiaries a flat $50/month copay for certain weight-loss GLP-1s — such as Wegovy and Zepbound — from July 1, 2026 through December 31, 2027.
Why weight loss isn’t covered. A federal law from 2003 prohibits Medicare Part D from paying for drugs “used for weight loss.” That’s a statute, not an Aetna choice.
The three doors that are open
| Reason | Drugs covered | Note |
|---|---|---|
| Type 2 diabetes | Ozempic, Mounjaro, Rybelsus | Prior approval required |
| Heart-risk reduction | Wegovy | Adults with heart disease and excess weight; prior approval required |
| Obstructive sleep apnea | Zepbound | Adults with obesity and moderate-to-severe OSA; prior approval required |
The new $50/month Medicare GLP-1 Bridge
The Medicare GLP-1 Bridge is a temporary government program from CMS that gives eligible Medicare Part D members — including those on Aetna plans — a flat $50 monthly copay for certain GLP-1 weight-management drugs. It runs July 1, 2026 through December 31, 2027.
Straight from CMS: the Bridge runs outside the regular Part D benefit, so your Part D plan doesn’t have to opt in; the Part D deductible doesn’t apply; and the $50 copay doesn’t count toward your “true out-of-pocket” total. Eligibility is based on BMI and other clinical criteria.
Does Aetna Better Health or Medicaid cover GLP-1 drugs?
Aetna Better Health and Medicaid coverage is state-specific, so neither the commercial Aetna rules nor the Medicare rules answer it. Whether a GLP-1 is covered depends on your state’s Medicaid drug list — and the answer can be a clear yes in one state and a clear no in another.
A real example: members on Aetna Better Health in Oklahoma have had coverage for Wegovy, while members in Florida have not. Same insurer brand, opposite answers — because Medicaid is run state by state.
Get the Medicaid-specific GLP-1 checklist for your state →What will you actually pay?
With coverage, your GLP-1 cost is a copay, not the sticker price — and it’s set by your specific plan. Without coverage, list prices run roughly $1,350/month for Wegovy and around $1,000/month for Ozempic. If you’re denied, the realistic options are an appeal, a manufacturer savings card (commercial plans only), the $50 Medicare Bridge if you’re eligible, or an FDA-approved cash-pay program.
| Route | What you pay | Who it’s for |
|---|---|---|
| Aetna coverage (approved) | A plan-specific copay. In Ro’s coverage-checker data, half of covered patients paid $50/month or less. | You meet the criteria and your plan includes the benefit. |
| Manufacturer savings card | As little as $25/month for eligible patients. Commercial insurance only — not valid with Medicare, Medicaid, or Tricare. | Commercially insured patients whose plan covers the drug. |
| Medicare GLP-1 Bridge | Flat $50/month, July 1, 2026–Dec 31, 2027. | Eligible Medicare Part D members. |
| FDA-approved cash-pay (e.g., Ro) | Wegovy pill $149 first month / $199–$299 after; Foundayo $149 / $199–$299; Wegovy pen $199 / $199–$399; Zepbound KwikPen $299 / $399–$449. Membership billed separately. | No coverage, but you want the real brand medication. |
| Retail / list price (no help) | ~$1,350/month Wegovy; ~$900–$1,100 Ozempic. | The number to avoid — almost no one should pay this. |
What to do if Aetna denies your GLP-1
The fix for an Aetna denial depends entirely on why you were denied. The five common reasons are: prior-auth criteria not met, step therapy, non-formulary, quantity limit, and excluded benefit — and each has a different solution. The first thing to do is read the denial letter and find which one you got.
Don’t panic, and don’t refile blindly. Match your denial to the right move:
| # | Denial reason | The fix |
|---|---|---|
| 1 | “Prior authorization criteria not met” | Most common and most fixable. It usually means a document was missing (BMI, the 6-month program, a diagnosis code). Resubmit with complete documentation. |
| 2 | “Step therapy required” | Your plan wants you to try a cheaper drug first. Ask which drug, then either try it or request a step-therapy exception with proof you already tried it or can’t take it. |
| 3 | “Non-formulary” | The drug isn’t on your plan’s list. Request a formulary exception with evidence that the covered alternatives won’t work for you. |
| 4 | “Quantity limit” | They’ll cover it, but not the amount prescribed. Your prescriber documents why your dose is medically necessary. |
| 5 | “Excluded benefit” | The hard one — appeals usually can’t override a carve-out. Ask HR whether the benefit can be added at open enrollment, check whether a covered diagnosis applies, or move to a cash-pay path. |
How fast must Aetna decide? Go by the deadline printed on your denial or coverage notice. As one benchmark, Aetna says it provides a coverage decision within 24 hours of receiving an expedited (urgent) medical-exception request. Medicare and other appeal routes have their own deadlines.
What if your plan excludes weight-loss drugs completely?
If your Aetna plan carves out weight-loss medications, prior authorization won’t help — you need a different strategy. Your four options are: qualify under a different covered diagnosis, ask HR whether the benefit can be added, use an FDA-approved cash-pay program, or compare compounded cash-pay options as a last resort.
Option 1 — Check for a covered diagnosis
This is the highest-value move and the most overlooked. Do you have type 2 diabetes, established heart disease with excess weight, moderate-to-severe sleep apnea, or noncirrhotic MASH? Any one of those can flip an excluded weight-loss request into a covered medical one. Talk to your doctor honestly about your full health picture.
Option 2 — Ask HR the exact question
Try this script: “Does our Aetna pharmacy plan exclude weight-loss medications, or does it cover FDA-approved anti-obesity drugs with prior authorization?” Some employers add the benefit at open enrollment if enough people ask.
Option 3 — FDA-approved cash-pay
If coverage is off the table, you can still get the real, brand-name medication at far below retail. Through Ro, FDA-approved cash-pay currently starts at $149 for the first month for the Wegovy pill ($199–$299 after) and runs $299 first month / $399–$449 for the Zepbound KwikPen. Ro also checks your insurance for free first, so you confirm the exclusion before paying out of pocket.
See FDA-approved GLP-1 options that start at $149 for the first month → (sponsored affiliate link, opens in a new tab)Option 4 — Compounded cash-pay (read carefully)
Some cash-pay telehealth programs offer compounded semaglutide or tirzepatide at lower prices. The honest truth: compounded GLP-1 medications are not FDA-approved finished drugs, they are not the same as Wegovy, Zepbound, Ozempic, Mounjaro, or Foundayo, and they should be evaluated only with a licensed clinician and a properly licensed pharmacy. They can fit certain situations, but they belong in a different category.
Compare FDA-approved vs. compounded cash-pay paths with our free matcher →How to check your exact Aetna GLP-1 coverage in 2 minutes
The fastest way to know your real coverage is to look it up using your specific pharmacy plan name. Log in to your Aetna member portal or open your plan’s drug list, search each drug by brand name, and write down whether it’s covered, what tier it’s on, and whether it needs prior approval, step therapy, or has quantity limits. Then call the number on your card to confirm your cost.
Step 1 — Find your pharmacy plan name
It's on your Summary of Benefits and Coverage, or you'll see it after logging in to your Aetna account. Aetna needs this to show your coverage, not a generic list.
Step 2 — Search each drug by exact name
Look up: Wegovy, Wegovy oral tablet, Zepbound, Zepbound KwikPen, Ozempic, Mounjaro, Rybelsus, Trulicity, Saxenda, Foundayo, and the ingredients semaglutide, tirzepatide, and orforglipron.
Step 3 — Write down the status for each
Note: Covered? What tier? Prior approval needed? Step therapy? Quantity limit? Non-formulary? Diagnosis required? Estimated cost?
Step 4 — Call and ask the exact questions
Use this: "For my plan, is [drug] covered under the pharmacy benefit for [my reason]? Are weight-loss medications excluded? What exact prior-authorization criteria does my prescriber need to submit?"
Which path fits you?
The right GLP-1 path depends on why you want it and what your plan actually covers. Diabetes, weight loss, sleep apnea, Medicare, Medicaid, and excluded-benefit cases each need a different first step.
- ✓You have type 2 diabetes → Start in the diabetes lane: Ozempic, Mounjaro, Rybelsus, or Trulicity.
- ✓You want weight loss and your plan covers it → Start with Wegovy (the most consistent yes), then check Zepbound and Foundayo.
- ✓You specifically want tirzepatide → Check Zepbound for weight loss or sleep apnea. Only ask for Mounjaro if your use is diabetes. Don't mix them up.
- ✓You want a pill → Check the Wegovy oral tablet and Foundayo — both FDA-approved. Don't swap in compounded products on a coverage question.
- ✓You're on Medicare → Check the diabetes / heart / sleep-apnea doors and the $50 Bridge. Don't assume weight-loss coverage.
- ✓You're on Medicaid → Check your state's Medicaid drug list; it's state-specific.
- ✓Your plan excludes weight loss → Go to the carve-out playbook: covered diagnosis, HR, FDA-approved cash-pay, then compounded as a clearly-separated last resort.
How we verified this guide
We built this guide from primary and authoritative sources: Aetna’s public 2026 plan drug guides and Clinical Policy Bulletins, Aetna’s Medicare and employer coverage pages, CVS Caremark’s 2026 formulary announcements, the CMS page for the Medicare GLP-1 Bridge, and the FDA’s approval records. We used patient forums only to understand where people get confused — not as evidence of coverage. Your exact coverage can still differ, because Aetna requires your pharmacy plan name or member login for personalized results.
What we verified (June 17, 2026):
- Aetna’s weight-loss GLP-1 prior-authorization criteria (BMI 30, or 27 with a comorbidity; 6-month program; 5% to continue) — Aetna Clinical Policy Bulletin
- That employers choose whether to include weight-loss GLP-1 coverage, with a real Aetna-administered fund dropping that coverage as of January 1, 2026
- The CVS Caremark timeline (Zepbound dropped July 1, 2025; Foundayo block removed June 1, 2026; Zepbound returns October 1, 2026) — CVS Health newsroom
- Medicare’s weight-loss exclusion and the GLP-1 Bridge ($50/month, July 1, 2026–December 31, 2027, run outside Part D) — Aetna Medicare pages and CMS
- Current cash-pay and list prices — Ro and manufacturer sources
Sources checked:
- CVS Health — GLP-1 weight-management formulary update (May 28, 2026)
- CMS — Medicare GLP-1 Bridge
- Aetna — “Does Medicare Part D cover GLP-1 drugs like Ozempic?”
- Aetna — Weight Reduction Clinical Policy Bulletin (CPB 0039)
- Aetna — GLP-1 Benefit Coverage (employers)
- FDA — Foundayo (orforglipron) approval; Zepbound obstructive sleep apnea approval; Wegovy cardiovascular indication
- Ro — Weight Loss Program Pricing; GLP-1 Insurance Coverage Checker; 2025 Coverage Checker Report
- SingleCare, NiceRx — Aetna prior-authorization criteria corroboration
Related guides
Frequently asked questions
What GLP-1 does Aetna cover most often?
For diabetes, Aetna most often covers Ozempic, Mounjaro, and Rybelsus (often with prior approval). For weight loss, Wegovy is the most consistently covered option on plans that include weight-loss coverage, while Zepbound depends on the specific plan.
Does Aetna cover Wegovy for weight loss?
Often yes, on commercial plans with prior authorization, but only if your plan includes weight-loss drug coverage. Wegovy has been Aetna's preferred weight-loss GLP-1 since mid-2025.
Does Aetna cover Zepbound?
It depends on your plan. Zepbound is covered on some Aetna plans and listed as excluded on others. CVS Caremark dropped it from its standard formulary in July 2025 and is adding it back as a preferred option on October 1, 2026 for plans that elect coverage.
Does Aetna cover Ozempic for weight loss?
Generally no. Aetna covers Ozempic for type 2 diabetes, not weight loss alone, so a weight-loss prescription for Ozempic without a diabetes diagnosis should be expected to be denied. Ask about Wegovy instead.
Does Aetna cover Mounjaro without diabetes?
Generally no. Mounjaro is covered as a diabetes drug. For weight loss, the matching FDA-approved tirzepatide product is Zepbound, not Mounjaro.
What BMI does Aetna require for GLP-1 weight-loss coverage?
Aetna's published criteria for these GLP-1s generally use a BMI of 30 or higher, or 27 or higher with a weight-related condition such as high blood pressure, type 2 diabetes, or sleep apnea. Thresholds can vary by plan, so confirm yours.
Does Aetna require 6 months of weight management before Wegovy or Zepbound?
Yes, for the standard weight-loss path, documentation of at least 6 months in a comprehensive weight-management program is required. This requirement is generally waived for the heart-disease path (Wegovy) and the sleep-apnea path (Zepbound).
Does Aetna cover the Wegovy pill or Foundayo?
Some Aetna 2026 materials list the Wegovy oral tablet, and Foundayo (approved April 1, 2026) became coverable after CVS Caremark removed its new-to-market block on June 1, 2026, but coverage is plan-by-plan and still settling. Confirm your specific plan.
Does Aetna cover Wegovy for MASH?
Aetna's current policy includes a path for Wegovy injection for noncirrhotic MASH (a fatty-liver condition) with moderate-to-advanced scarring. It excludes Wegovy HD and the Wegovy tablet for that path, and it is separate from plain weight-loss coverage.
Does Aetna Medicare cover GLP-1 for weight loss?
No. Federal law prohibits Medicare Part D from covering drugs for weight loss. Aetna Medicare can cover GLP-1s for diabetes, heart-risk reduction, or sleep apnea, and the separate Medicare GLP-1 Bridge offers a $50/month copay for certain weight-loss GLP-1s such as Wegovy and Zepbound from July 2026 through December 2027.
Does Aetna Better Health or Medicaid cover GLP-1s?
It is state-specific. Coverage and the rules around it depend on your state's Medicaid drug list; for example, Aetna Better Health has covered Wegovy in Oklahoma but not in Florida.
Can I appeal if Aetna denies my GLP-1?
Yes, but the right approach depends on the denial reason: criteria not met, step therapy, non-formulary, quantity limit, or excluded benefit. An excluded-benefit denial usually cannot be fixed by appeal; the others often can.
How much does a GLP-1 cost with Aetna?
With coverage it is a plan-specific copay; in Ro's coverage-checker data, half of covered patients paid $50 a month or less. Without coverage, list prices run roughly $1,350 a month for Wegovy and around $1,000 for Ozempic, though savings cards, the Medicare Bridge, and cash-pay programs cost far less.
Still not sure which GLP-1 program is right for you?
Take our free 60-second matching quiz. You’ve done the hard part — you’ve decided you want to make this change. Let us help you find the path that actually works for your plan, your budget, and your situation.
Find My GLP-1 Path →Free · 60 seconds · no account needed
Your situation changes the answer
Find My GLP-1 Path
The right GLP-1 provider isn't the same for everyone. It depends on your state, your insurance and formulary, whether you want an FDA-approved or compounded medication, your preferred route (injection or oral), and your budget. Because a general answer can't resolve those for you, use The RX Index's Find My GLP-1 Path tool to get a personalized provider match with source-verified pricing before you choose.
- What it asks: your state, insurance situation, medication preference, budget, and support needs
- What you get: a personalized shortlist of GLP-1 providers matched to your situation, with verified pricing and the right questions to ask
- Cost: free · about 60 seconds · no signup